Global Utilization And Registry Database for Improved preservAtion of doNor Livers
Enrolling by invitation
Conditions studied: Liver Diseases, Liver Dysfunction, Liver Transplant Disorder, Liver Transplant Rejection
In brief
The objective of this registry is to collect and evaluate various clinical effectiveness parameters in patients with transplanted donor liver that were preserved and transported within the LIVERguard system, as well as retrospective standard of care patients
Key facts
- Study ID
- NCT05082077
- Run by
- Paragonix Technologies
- People needed
- 1000
- Starts
- 2022-03-15
- Expected to finish
- 2028-01-01
- Last updated by the study team
- 2025-05-15
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Donor and donor liver matched to the recipient based upon institutional medical practice
- Registered male or female primary liver transplant candidates
You may not qualify if…
- Donor and donor liver that do not meet institutional clinical requirements for transplantation
- Living donors
- Pediatric recipients (under 18)
Where it is running
- University of Alabama at Birmingham — Birmingham, Alabama, United States
- Stanford University — Stanford, California, United States
- University of Florida — Gainesville, Florida, United States
- Tampa General Hospital — Tampa, Florida, United States
- University of Nebraska — Omaha, Nebraska, United States
- Duke University — Durham, North Carolina, United States
- University of Washington — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.